Frances Levin

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Treatment of cannabis use disorders: a review of the literature
    Benjamin R Nordstrom
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Addict 16:331-42. 2007
  2. pmc A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence
    Alex M Secora
    Division of Substance Abuse, New York State Psychiatric Institute, New York, NY 10032, USA
    J Addict Dis 29:325-37. 2010
  3. pmc A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders
    Frances R Levin
    New York State Psychiatric Institute, Division of Substance Abuse, 1051 Riverside Drive, New York, NY 10032, USA
    Addiction 108:1084-94. 2013
  4. ncbi request reprint Use of standardized patients to evaluate the physicians in residence program: a substance abuse training approach
    F R Levin
    Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York, USA
    J Addict Dis 18:39-50. 1999
  5. pmc Use of dronabinol for cannabis dependence: two case reports and review
    Frances R Levin
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Addict 17:161-4. 2008
  6. ncbi request reprint Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders
    Frances Rudnick Levin
    Division on Substance Abuse, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    J Clin Psychiatry 68:9-14. 2007
  7. pmc Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol
    Frances R Levin
    New York State Psychiatric Institute, Division on Substance Abuse, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 106:65-8. 2010
  8. ncbi request reprint Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers
    Frances R Levin
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    J Addict Dis 25:33-41. 2006
  9. ncbi request reprint Bipolar disorder and substance abuse
    Frances R Levin
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA
    Biol Psychiatry 56:738-48. 2004
  10. ncbi request reprint Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community
    Frances Rudnick Levin
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive Unit 66, New York City, NY 10032, USA
    Addict Behav 29:1875-82. 2004

Detail Information

Publications63

  1. ncbi request reprint Treatment of cannabis use disorders: a review of the literature
    Benjamin R Nordstrom
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Addict 16:331-42. 2007
    ..We also review pertinent dual-diagnosis pharmacotherapy trials and discuss potential future directions in treatment research for the pharmacotherapy of cannabis dependence...
  2. pmc A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence
    Alex M Secora
    Division of Substance Abuse, New York State Psychiatric Institute, New York, NY 10032, USA
    J Addict Dis 29:325-37. 2010
    ..Based on the authors' results, they concluded that the additive effects of cannabis dependency and depression may only be limited to psychosocial domains and may not extend to cognitive functioning...
  3. pmc A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders
    Frances R Levin
    New York State Psychiatric Institute, Division of Substance Abuse, 1051 Riverside Drive, New York, NY 10032, USA
    Addiction 108:1084-94. 2013
    ..To evaluate whether venlafaxine-extended release (VEN-XR) is an effective treatment for cannabis dependence with concurrent depressive disorders...
  4. ncbi request reprint Use of standardized patients to evaluate the physicians in residence program: a substance abuse training approach
    F R Levin
    Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York, USA
    J Addict Dis 18:39-50. 1999
    ..Overall, self-report ratings showed a greater percent improvement than the counselor ratings. The PIR program may be an efficacious approach to teach substance abuse clinical skills to housestaff...
  5. pmc Use of dronabinol for cannabis dependence: two case reports and review
    Frances R Levin
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Addict 17:161-4. 2008
    ..The potential benefit, as well as questions that arise from the use of this medication in cannabis-abusing populations, is presented. Also, future areas of research that might be explored are discussed...
  6. ncbi request reprint Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders
    Frances Rudnick Levin
    Division on Substance Abuse, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    J Clin Psychiatry 68:9-14. 2007
    ....
  7. pmc Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol
    Frances R Levin
    New York State Psychiatric Institute, Division on Substance Abuse, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 106:65-8. 2010
    ..We propose that the lack of THCV detection may be due to the variability of available cannabis strains smoked by marijuana users in community settings...
  8. ncbi request reprint Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers
    Frances R Levin
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    J Addict Dis 25:33-41. 2006
    ....
  9. ncbi request reprint Bipolar disorder and substance abuse
    Frances R Levin
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA
    Biol Psychiatry 56:738-48. 2004
    ..Finally, we present suggestions for medications that might be tested for their efficacy in treating both disorders in specific subgroups of patients with bipolar and substance use disorders...
  10. ncbi request reprint Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community
    Frances Rudnick Levin
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive Unit 66, New York City, NY 10032, USA
    Addict Behav 29:1875-82. 2004
    ..Future investigations may be useful to determine whether pharmacologic or nonpharmacologic interventions might improve treatment outcome...
  11. ncbi request reprint Pergolide mesylate for cocaine abuse: a controlled preliminary trial
    F R Levin
    Department of Psychiatry, Columbia University New York State Psychiatric Institute, NY 10032, USA
    Am J Addict 8:120-7. 1999
    ..Comparing an agent to both an active control and placebo group may better predict whether a promising new agent will have clinical utility compared to the standard open trial...
  12. ncbi request reprint Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium
    Frances Rudnick Levin
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Am J Addict 13:21-32. 2004
    ..The design of a preliminary clinical trial should include a psychosocial/behavioral intervention emphasizing motivation and medication compliance and a placebo control group...
  13. pmc Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial
    Frances R Levin
    New York State Psychiatric Institute, Division of Substance Abuse, New York, NY 10032, USA
    Drug Alcohol Depend 116:142-50. 2011
    ..Future trials might test higher doses, combinations of dronabinol with other medications with complementary mechanisms, or with more potent behavioral interventions...
  14. ncbi request reprint Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients
    Wilfrid Noel Raby
    Substance Treatment and Research Service S T A R S, Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, NYC, NY 10032, USA
    Drug Alcohol Depend 81:283-92. 2006
    ..These results suggest that temperament dimensions may be important for identifying substance dependent patients more likely to benefit from pharmacological interventions for comorbid depressive disorders...
  15. pmc A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence
    Kenneth M Carpenter
    Division on Substance Abuse, New York State Psychiatric Institute, New York, USA
    Am J Addict 18:53-64. 2009
    ..The results indicate nefazodone and bupropion-sustained release may have limited efficacy in treating cannabis dependence...
  16. ncbi request reprint One-year follow-up study of suicide attempters treated for drug dependence
    Vito Agosti
    New York State Psychiatric Institute, Depression Evaluation Service, New York, New York 10032, USA
    Am J Addict 15:293-6. 2006
    ....
  17. pmc Training physicians to treat substance use disorders
    Soteri Polydorou
    Columbia University Medical Center New York State Psychiatric Institute, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Curr Psychiatry Rep 10:399-404. 2008
    ..Further integration of online training into current programs may expand and enhance training opportunities...
  18. doi request reprint A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients
    Wilfrid Noel Raby
    Division on Substance Abuse, New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York
    Am J Addict 23:68-75. 2014
    ..This study tested the hypothesis that the antidepressant venlafaxine would be an effective treatment for cocaine abusers with concurrent depressive disorders...
  19. ncbi request reprint Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence
    Vito Agosti
    New York State Psychiatric Institute, Substance Abuse Treatment Center, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Drug Alcohol Abuse 28:643-52. 2002
    ..The failure to identify comorbidity may lead to inadequate treatment, and a poorer prognosis...
  20. ncbi request reprint Early abstinence in cocaine dependence: influence of comorbid major depression
    Eric Rubin
    Division on Substance Abuse, Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, New York 10032, USA
    Am J Addict 16:283-90. 2007
    ..By Day 3, BDI scores improved for both CD and CD + MDD groups. The mood response to cocaine cessation among CD + MDD individuals resembled that of CD participants, contrary to some expectations...
  21. pmc Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use
    Erik W Gunderson
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Addict 17:149-54. 2008
    ..05), as did inquiry about current illicit drug use (p < .05). Continued efforts are needed to enhance educational initiatives for primary care physicians...
  22. doi request reprint Uses of coercion in addiction treatment: clinical aspects
    Maria A Sullivan
    Columbia College of Physicians and Surgeons New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Addict 17:36-47. 2008
    ..The philosophical, historical, and societal aspects of coerced treatment are considered...
  23. pmc Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder)
    Stephanie Collins Reed
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Horm Behav 54:185-93. 2008
    ..An altered serotonergic system in women with PMDD may be the underlying mechanism for the observed symptoms; correspondingly, treatment with specific serotonin reuptake inhibitors (SSRIs) remains the preferred treatment at this time...
  24. pmc Quetiapine treatment of zolpidem dependence
    John J Mariani
    New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Addict 16:426. 2007
  25. pmc Pediatric obesity: parallels with addiction and treatment recommendations
    Michelle C Acosta
    Department of Psychiatry, Columbia University, New York, NY, USA
    Harv Rev Psychiatry 16:80-96. 2008
    ..The parallels between addiction and obesity aid in developing novel interventions for pediatric obesity. Motivational enhancement and cognitive-behavioral strategies used in addiction treatment may prove to be beneficial...
  26. pmc The effects of progesterone pretreatment on the response to oral d-amphetamine in Women
    Stephanie C Reed
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Horm Behav 58:533-43. 2010
    ..Additional studies are needed to explore the modulatory role of progesterone on the effects of AMPH to determine whether progesterone has any clinical utility for AMPH abuse...
  27. pmc A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period
    Adam Bisaga
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Drug Alcohol Depend 111:97-104. 2010
    ..Targeting the latter subgroup may advance medication development efforts...
  28. ncbi request reprint Predictors of treatment contact among individuals with cannabis dependence
    Vito Agosti
    New York State Psychiatric Institute, 1051 Riverside Drive Box 51, New York, NY 10032, USA
    Am J Drug Alcohol Abuse 30:121-7. 2004
    ....
  29. pmc The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders
    Elias Dakwar
    Division of Substance Abuse, New York State Psychiatric Institute Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Harv Rev Psychiatry 17:254-67. 2009
    ..A brief discussion then integrates the research that has been completed thus far, elucidates the specific ways that meditation may be helpful for substance use disorders, and suggests new avenues for research...
  30. pmc Effects of research setting on observed depressive symptoms in marijuana users
    John J Mariani
    Division on Substance Abuse, New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA
    J Subst Abuse Treat 37:431-4. 2009
    ..e., treatment-seekers are more likely to be experiencing some degree of clinical distress), it is notable that treatment-seeking, and not marijuana use per se, is associated with significantly higher rates of depression...
  31. pmc Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review
    John J Mariani
    Division on Substance Abuse, New York State Psychiatric Institute, New York, New York 10032, USA
    Am J Drug Alcohol Abuse 34:683-91. 2008
    ..There is pre-clinical and clinical evidence that levetiracetam, a newer generation anticonvulsant medication, may be efficacious in the treatment of co-occurring alcohol use and anxiety disorders...
  32. pmc Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults?
    Vito Agosti
    New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Soc Psychiatry Psychiatr Epidemiol 44:120-4. 2009
    ..This article tests the hypothesis that remission from substance use disorders is associated with smoking cessation in nicotine dependent young adults...
  33. pmc Antisocial behavioral syndromes in cocaine and cannabis dependence
    John J Mariani
    New York State Psychiatric Institute, Division on Substance Abuse, New York, NY 10032, USA
    Am J Drug Alcohol Abuse 34:405-14. 2008
    ..Antisocial behavioral syndromes are commonly diagnosed in patients with SUD and future research should evaluate prognostic implications of AABS compared to ASPD in a variety of clinical treatment settings...
  34. ncbi request reprint Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia
    Evaristo Akerele
    Department of Psychiatry, Harlem Hospital, College of Physicians and Surgeons of Columbia University, New York, New York 10037, USA
    Am J Addict 16:260-8. 2007
    ..The data suggest some potential for the utility of olanzapine for the treatment of cocaine dependence in individuals with schizophrenia...
  35. pmc Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence
    Frances R Levin
    New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Subst Abuse Treat 34:80-9. 2008
    ....
  36. pmc Treatment strategies for co-occurring ADHD and substance use disorders
    John J Mariani
    New York State Psychiatric Institute, New York, New York, USA
    Am J Addict 16:45-54; quiz 55-6. 2007
    ..Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed...
  37. ncbi request reprint Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD
    Stephanie L Collins
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Drug Alcohol Depend 82:158-67. 2006
    ..Thus, oral MPH-SR is safe in combination with repeated cocaine doses and decreases some of the positive and reinforcing effects of cocaine in cocaine abusers with ADHD...
  38. ncbi request reprint A randomized placebo-controlled trial of gabapentin for cocaine dependence
    Adam Bisaga
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Drug Alcohol Depend 81:267-74. 2006
    ..Gabapentin is an anticonvulsant medication that increases human brain GABA levels. We evaluated the safety and efficacy of gabapentin combined with relapse-prevention therapy in the treatment of cocaine-dependent individuals...
  39. ncbi request reprint Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo
    Frances R Levin
    New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Drug Alcohol Depend 81:137-48. 2006
    ..Taken together, sustained-release methylphenidate or sustained-release bupropion did not provide a clear advantage over placebo in reducing ADHD symptoms or additional cocaine use in methadone-maintained patients...
  40. ncbi request reprint Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff
    Erik W Gunderson
    Department of Psychiatry, Division on Substance Abuse, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Addict Dis 24:1-18. 2005
    ..These findings suggest areas to be addressed in residency curricula on substance abuse...
  41. ncbi request reprint Pharmacotherapy for alcohol-related disorders: what clinicians should know
    John J Mariani
    Department of Psychiatry, Division on Substance Abuse, Columbia University, College of Physicians and Surgeons, USA
    Harv Rev Psychiatry 12:351-66. 2004
    ..The routine exclusion of alcohol-dependent patients from pharmacotherapy trials of psychiatric disorders presents a barrier to gathering more data. Recommendations for future research are discussed...
  42. ncbi request reprint Utility of lead-in period in cocaine dependence pharmacotherapy trials
    Adam Bisaga
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, NY, USA
    Drug Alcohol Depend 77:7-11. 2005
    ..Findings of this study suggest that route and level of cocaine use during lead-in be used as a covariate in models testing treatment effect...
  43. ncbi request reprint Treatment of depression in patients with opiate dependence
    Edward V Nunes
    New York State Psychiatric Institute, and Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Biol Psychiatry 56:793-802. 2004
    ..Research is needed on such integrated models of care and treatment algorithms to determine their efficacy and cost effectiveness...
  44. ncbi request reprint Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action
    CHARLES P O'BRIEN
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
    Biol Psychiatry 56:703-13. 2004
  45. ncbi request reprint Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis
    Edward V Nunes
    Depression Evaluation Service, New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York 10032, USA
    JAMA 291:1887-96. 2004
    ..Depression and substance abuse are common and costly disorders that frequently co-occur, but controversy about effective treatment for patients with both disorders persists...
  46. ncbi request reprint Response to alcohol in females with a paternal history of alcoholism
    Suzette M Evans
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Psychopharmacology (Berl) 169:10-20. 2003
    ..g. lower ratings of intoxication) than males without a family history of alcoholism (FHN). The purpose of this pilot study was to determine if FHP females also showed a reduced sensitivity to alcohol compared to FHN females...
  47. ncbi request reprint Attention-deficit/hyperactivity disorder and early-onset substance use disorders
    Jeffrey J Wilson
    Division on Substance Abuse, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 15:751-63. 2005
    ..More research is needed to definitively assess the effectiveness and safety of medications in this population of youths with ADHD and SUD...
  48. ncbi request reprint Adult ADHD and substance abuse: diagnostic and treatment issues
    Aparna S Kalbag
    New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    Subst Use Misuse 40:1955-81, 2043-8. 2005
    ..The present review discusses diagnostic assessment issues, prevalence, comorbidity, pharmacotherapy, and psychological interventions in substance-abusing adults with ADHD...
  49. ncbi request reprint A pilot double-blind treatment trial of memantine for alcohol dependence
    Suzette M Evans
    New York State Psychiatric Institute, New York, New York 10032, USA
    Alcohol Clin Exp Res 31:775-82. 2007
    ..This 16-week double-blind outpatient pilot clinical trial determined if memantine was more effective than placebo at reducing alcohol use in actively drinking alcohol-dependent patients...
  50. ncbi request reprint Predictors of cannabis dependence recovery among epidemiological survey respondents in the United States
    Vito Agosti
    New York State Psychiatric Institute, New York, New York 10032, USA
    Am J Drug Alcohol Abuse 33:81-8. 2007
    ..Recovery was defined as the absence of Cannabis Dependence and Cannabis Abuse during the past year. Logistic Regression analysis revealed that older age, marriage, and non-daily cannabis use were positively associated with recovery...
  51. pmc Evaluation of a combined online and in person training in the use of buprenorphine
    Erik W Gunderson
    Columbia University College of Physicians and Surgeon and New York State Psychiatric Institute, New York, NY, USA
    Subst Abus 27:39-45. 2006
    ..Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation...
  52. ncbi request reprint Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome
    Efrat Aharonovich
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Am J Drug Alcohol Abuse 32:629-35. 2006
    ..02). This study is the first to examine concurrent cannabis use in cocaine dependent patients diagnosed with ADHD...
  53. ncbi request reprint Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence
    Daniel J Brooks
    New York State Psychiatry Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, USA
    J Addict Dis 25:15-25. 2006
    ..Diagnostic services capable of identifying cognitive deficits among MMP with ADHD and/or CD are needed to maximize the likelihood of treatment success and to serve as an indicator for the efficacy of therapeutic approaches...
  54. ncbi request reprint Treating depression in substance abusers
    Edward V Nunes
    New York State Psychiatric Institute, 1051 Riverside Drive Unit 51, New York, NY 10032, USA
    Curr Psychiatry Rep 8:363-70. 2006
    ....
  55. ncbi request reprint The effects of alcohol and drug dependence on the course of depression
    Vito Agosti
    Substance Use Research Center, New York State Psychiatric Institute, New York, New York 10032, USA
    Am J Addict 15:71-5. 2006
    ..This study analyzed data from the National Comorbidity Survey (NCS). Among respondents with lifetime SUD and unipolar depression, current SUD increased the risk (OR = 2.9) of past year depression and anxiety disorders (OR = 2.2)...
  56. ncbi request reprint Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder
    Frances R Levin
    Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York 10032, USA
    J Addict Dis 21:1-16. 2002
    ..However, a future study directly comparing BPR to MPH in a double-blind placebo-controlled trial is needed...
  57. ncbi request reprint Verbal abilities as predictors of retention among adolescents in a therapeutic community
    Jeffrey J Wilson
    Department of Psychiatry, Division on Substance Abuse, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, 1051 Riverside Drive, Box 66, New York, NY 10032, USA
    Child Psychiatry Hum Dev 36:393-401. 2006
    ..Remediation of verbal communication skills may be an overlooked aspect of the therapeutic process in treating adolescent substance abusers...
  58. ncbi request reprint Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo
    Frances R Levin
    New York State Psychiatric Institute, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Drug Alcohol Depend 87:20-9. 2007
    ....
  59. pmc Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism
    Suzette M Evans
    New York State Psychiatric Institute and Departmentof Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Drug Alcohol Depend 114:18-30. 2011
    ....
  60. pmc Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes
    John J Mariani
    New York State Psychiatric Institute, Division on Substance Abuse, 1051 Riverside Drive, Unit 66, New York, NY 10032, USA
    Drug Alcohol Depend 113:249-51. 2011
    ..Individual variability in use practices limits the utility of this method to estimating within-subject comparisons, rather than between subject comparisons...
  61. ncbi request reprint Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis
    Frances R Levin
    New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, USA
    J Clin Psychiatry 68:e18. 2007
    ..If proper attention is paid to age-appropriate symptoms of ADHD, and careful longitudinal data are obtained from patients presenting with ADHD or SUD, proper treatment can be given to patients with these comorbid disorders...
  62. doi request reprint Comorbid psychiatric and substance abuse disorders: recent treatment research
    Paula Riggs
    Department of Psychiatry, University of Colorado Health Science Cneter, Denver, CO 80224, USA
    Subst Abus 29:51-63. 2008
    ..Treatment of ADHD and substance use disorders in adults; 3. Effects of substance abuse on the onset, severity, and treatment of schizophrenia. Recommendations for further research will be presented...
  63. ncbi request reprint Effects of HIV triple therapy on methadone levels
    Evaristo O Akerele
    Division of Substance Abuse, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Addict 11:308-14. 2002
    ..These preliminary findings suggest that triple therapy may increase the rate of methadone metabolism, though further studies are warranted...

Research Grants30

  1. Combined Pharmacotherapies for Cocaine Dependence
    Frances Levin; Fiscal Year: 2006
    ..3. To explore a set of related secondary outcomes (treatment retention, global functioning, and HIV risk behavior) as well as moderators and mediators potentially reflective of mechanism of action. ..
  2. RESEARCH FELLOWSHIP IN SUBSTANCE ABUSE DISORDERS
    Frances Levin; Fiscal Year: 2007
    ..Currently, there are 16 faculty members within the Division of which 9 are capable of serving as mentors. This sustained growth demonstrates how vibrant the Division on Substance Abuse is for young investigators. ..
  3. TREATMENT OF SUBSTANCE ABUSE AND PSYCHIATRIC COMORBIDITY
    Frances Levin; Fiscal Year: 2007
    ..Finally, the applicant will continue to contribute to a variety of educational activities at the National and local level, provide ongoing mentorship to young clinical investigators, and offer service to the Substance Abuse field. ..
  4. Marijuana Dependence & Depression: Venlafaxine Treatment
    Frances Levin; Fiscal Year: 2006
    ..3. To examine the relationship between medication treatment, mood improvement, cognitive functioning and improvement in marijuana abuse using mediational analyses. ..
  5. Combined Pharmacotherapies for Cocaine Dependence
    Frances Levin; Fiscal Year: 2007
    ..3. To explore a set of related secondary outcomes (treatment retention, global functioning, and HIV risk behavior) as well as moderators and mediators potentially reflective of mechanism of action. ..
  6. Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence
    Frances Levin; Fiscal Year: 2007
    ..Here a nearly unique opportunity exists to treat two conditions, ADHD and cocaine dependence, with a single medication, hopefully leading to improved treated outcome in this difficult-to-treat population. ..
  7. Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence
    Frances Levin; Fiscal Year: 2009
    ..Here a nearly unique opportunity exists to treat two conditions, ADHD and cocaine dependence, with a single medication, hopefully leading to improved treated outcome in this difficult-to-treat population. ..
  8. Marijuana Dependence & Depression: Venlafaxine Treatment
    Frances Levin; Fiscal Year: 2006
    ..3. To examine the relationship between medication treatment, mood improvement, cognitive functioning and improvement in marijuana abuse using mediational analyses. ..
  9. Marijuana Dependence & Depression: Venlafaxine Treatment
    Frances Levin; Fiscal Year: 2005
    ..3. To examine the relationship between medication treatment, mood improvement, cognitive functioning and improvement in marijuana abuse using mediational analyses. ..
  10. TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
    Frances Levin; Fiscal Year: 1999
    ..Overall, this proposal will provide a better understanding of the relationship between ADHD and substance abuse, better diagnostic evaluation, and improved pharmacologic treatment approaches for this sub-population. ..
  11. METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD
    Frances Levin; Fiscal Year: 1999
    ..2) To determine if sustained-release MPH is more effective than placebo in reducing ADHD symptoms in cocaine abusers with adult ADHD. 3) To determine if improvement in ADHD symptoms precedes a reduction in cocaine use. ..
  12. TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
    Frances Levin; Fiscal Year: 1999
    ..Overall, this proposal will provide a better understanding of the relationship between ADHD and substance abuse, better diagnostic evaluation, and improved pharmacologic treatment approaches for this sub-population. ..
  13. METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD
    Frances Levin; Fiscal Year: 2000
    ..2) To determine if sustained-release MPH is more effective than placebo in reducing ADHD symptoms in cocaine abusers with adult ADHD. 3) To determine if improvement in ADHD symptoms precedes a reduction in cocaine use. ..
  14. TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
    Frances Levin; Fiscal Year: 2000
    ..Overall, this proposal will provide a better understanding of the relationship between ADHD and substance abuse, better diagnostic evaluation, and improved pharmacologic treatment approaches for this sub-population. ..
  15. TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
    Frances Levin; Fiscal Year: 2001
    ..Overall, this proposal will provide a better understanding of the relationship between ADHD and substance abuse, better diagnostic evaluation, and improved pharmacologic treatment approaches for this sub-population. ..
  16. METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD
    Frances Levin; Fiscal Year: 2001
    ..2) To determine if sustained-release MPH is more effective than placebo in reducing ADHD symptoms in cocaine abusers with adult ADHD. 3) To determine if improvement in ADHD symptoms precedes a reduction in cocaine use. ..
  17. TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
    Frances Levin; Fiscal Year: 2002
    ..Overall, this proposal will provide a better understanding of the relationship between ADHD and substance abuse, better diagnostic evaluation, and improved pharmacologic treatment approaches for this sub-population. ..
  18. METHYLPHENIDATE TREATMENT FOR COCAINE ABUSE AND ADHD
    Frances Levin; Fiscal Year: 2002
    ..2) To determine if sustained-release MPH is more effective than placebo in reducing ADHD symptoms in cocaine abusers with adult ADHD. 3) To determine if improvement in ADHD symptoms precedes a reduction in cocaine use. ..
  19. Marijuana Dependence & Depression: Venlafaxine Treatment
    Frances Levin; Fiscal Year: 2003
    ..3. To examine the relationship between medication treatment, mood improvement, cognitive functioning and improvement in marijuana abuse using mediational analyses. ..
  20. Marijuana Dependence & Depression: Venlafaxine Treatment
    Frances Levin; Fiscal Year: 2004
    ..3. To examine the relationship between medication treatment, mood improvement, cognitive functioning and improvement in marijuana abuse using mediational analyses. ..
  21. Marijuana Abusing ADHD Teens: Atomoxetine Treatment
    Frances Levin; Fiscal Year: 2004
    ..4. To examine the relationship between medication treatment, reduction in ADHD symptoms, and improvement in retention and/or progress in treatment using mediational analyses. ..
  22. Extended Release Mixed Amphetamine Salts for Adult ADHD and Cocaine Dependence
    Frances Rudnick Levin; Fiscal Year: 2010
    ..Here a nearly unique opportunity exists to treat two conditions, ADHD and cocaine dependence, with a single medication, hopefully leading to improved treated outcome in this difficult-to-treat population. ..